Marek Mirowski
Lodz, LD 90151, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Advances in the Treatment of Ulcerative Colitis-From Conventional Therapies to Targeted Biologics and Small Molecules.
Journal: International journal of molecular sciences
Published: December 31, 2025
In Silico and Wet Analysis of BAX Gene G-248A Polymorphism and mRNA Expression in Peptic Ulcer Disease and Gastric Cancer.
Journal: Current issues in molecular biology
Published: November 06, 2025
Monoclonal Antibodies: Historical Perspective and Current Trends in Biological Drug Development.
Journal: International journal of molecular sciences
Published: July 28, 2025
Historical Perspective and Current Trends in Anticancer Drug Development.
Journal: Cancers
Published: April 16, 2024
Anticancer Properties of 3-Dietoxyphosphorylfuroquinoline-4,9-dione.
Journal: Molecules (Basel, Switzerland)
Published: February 28, 2023
Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis.
Journal: International journal of molecular sciences
Published: June 01, 2022
Changes in the expression of membrane type-matrix metalloproteinases genes (MMP14, MMP15, MMP16, MMP24) during treatment and their potential impact on the survival of patients with non-small cell lung cancer (NSCLC).
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 15, 2021
Synthesis of 2,2,6-Trisubstituted 5-Methylidene-tetrahydropyran-4-ones with Anticancer Activity.
Journal: Molecules (Basel, Switzerland)
Published: January 14, 2020
The impact of ABCB1 gene polymorphism and its expression on non-small-cell lung cancer development, progression and therapy - preliminary report.
Journal: Scientific reports
Published: November 22, 2019
New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer Agents.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 07, 2019
The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility.
Journal: OncoTargets and therapy
Published: March 19, 2019
Last Updated: 09/26/2026